Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2017 | Plasma tau levels and Alzheimer’s disease: what’s the relationship?

Michelle Mielke • 29 Aug 2017
AAIC 2017
Alzheimer’s Disease

In patients suffering from Alzheimer’s disease (AD), it has been suggested that plasma tau levels can vary depending on the severity of the condition. Michelle Mielke, PhD from the Mayo Clinic, Rochester, MN talks to us about her recent study which examined the relationship between plasma tau levels and cognition. Dr Mielke discusses the results and the conclusions made regarding tau levels as a biomarker for AD. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.

More from Michelle Mielke

The advantage of blood-based screening for Alzheimer’s disease
0:56
The advantage of blood-based screening for Alzheimer’s disease
Michelle Mielke • 29 Aug 2017
Our current understanding of biomarkers and the progression of Alzheimer’s
0:49
Our current understanding of biomarkers and the progression of Alzheimer’s
Michelle Mielke • 29 Aug 2017

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals